Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    SH02 - WCLC 2016 Scientific Highlights - SCLC, Mesothelioma and Thymic Malignancies

    • Type: Scientific Highlights
    • Track: SCLC/Neuroendocrine Tumors
    • Presentations: 3
    • Moderators:R. Hassan
    • Coordinates: 12/05/2016, 07:30 - 08:30, Hall C7
  • +

    SC06 - Novel Therapies in Malignant Pleural Mesothelioma and Thymic Malignancies

    • Type: Science Session
    • Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
    • Presentations: 4
    • Moderators:A. Nowak
    • Coordinates: 12/05/2016, 14:30 - 15:45, Strauss 3
  • +

    OA13 - Immunotherapy in Malignant Pleural Mesothelioma: Current Status of Trials and New Approaches

    • Type: Oral Session
    • Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
    • Presentations: 8
    • Moderators:R. Hassan
    • Coordinates: 12/06/2016, 14:20 - 15:50, Stolz 1
  • +

    P2.06 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Scientific Co-Operation/Research Groups (Clinical Trials in Progress should be submitted in this category)
    • Presentations: 47
    • Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P2.06-025 - DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In

      14:30 - 14:30  |  Author(s): A. Nowak

      • Abstract

      Loading...

    • +

      P2.06-026 - A Phase II Trial of the Oral FGF Receptor Inhibitor AZD4547 as 2nd or 3rd Line Therapy in Malignant Pleural Mesothelioma - Trial in Progress

      14:30 - 14:30  |  Author(s): W. Lam

      • Abstract

      Loading...

  • +

    OA22 - Novel Trials and Biomarkers in Malignant Pleural Mesothelioma

    • Type: Oral Session
    • Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
    • Presentations: 8
    • Moderators:H. Pass
    • Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 3
    • +

      OA22.02 - Nintedanib plus Pemetrexed/Cisplatin in Patients with MPM: Phase II Findings from the Placebo-Controlled LUME-Meso Trial

      14:30 - 14:40  |  Author(s): F. Grosso

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.